Search

Hai V Tran

Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )

Most Active Art Unit
2845
Art Unit(s)
2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821
Total Applications
1291
Issued Applications
923
Pending Applications
111
Abandoned Applications
257

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17748223 [patent_doc_number] => 20220226426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR ALLERGY [patent_app_type] => utility [patent_app_number] => 17/613832 [patent_app_country] => US [patent_app_date] => 2020-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7029 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613832 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/613832
OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR ALLERGY May 22, 2020 Pending
Array ( [id] => 16628712 [patent_doc_number] => 20210047365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => METHODS AND SYSTEMS FOR SOLID PHASE PEPTIDE SYNTHESIS [patent_app_type] => utility [patent_app_number] => 16/874824 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874824 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/874824
Methods and systems for solid phase peptide synthesis May 14, 2020 Issued
Array ( [id] => 16389607 [patent_doc_number] => 20200330548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS [patent_app_type] => utility [patent_app_number] => 16/874218 [patent_app_country] => US [patent_app_date] => 2020-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21649 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874218 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/874218
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS May 13, 2020 Abandoned
Array ( [id] => 16598052 [patent_doc_number] => 20210024583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => COMPOSITIONS AND METHODS FOR PEPTIDE MEDIATED OLIGONUCLEOTIDE DELIVERY TO THE CENTRAL NERVOUS SYSTEM [patent_app_type] => utility [patent_app_number] => 15/931182 [patent_app_country] => US [patent_app_date] => 2020-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13786 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931182 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/931182
COMPOSITIONS AND METHODS FOR PEPTIDE MEDIATED OLIGONUCLEOTIDE DELIVERY TO THE CENTRAL NERVOUS SYSTEM May 12, 2020 Abandoned
Array ( [id] => 16555760 [patent_doc_number] => 20210000908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => HMGB1 ANTAGONIST TREATMENT OF SEVERE SEPSIS [patent_app_type] => utility [patent_app_number] => 16/869905 [patent_app_country] => US [patent_app_date] => 2020-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869905 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/869905
HMGB1 antagonist treatment of severe sepsis May 7, 2020 Issued
Array ( [id] => 16359413 [patent_doc_number] => 20200316164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => FORMULATIONS AND METHODS FOR TREATING ULCERATIVE COLITIS [patent_app_type] => utility [patent_app_number] => 16/853352 [patent_app_country] => US [patent_app_date] => 2020-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13283 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853352 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/853352
FORMULATIONS AND METHODS FOR TREATING ULCERATIVE COLITIS Apr 19, 2020 Abandoned
Array ( [id] => 17911430 [patent_doc_number] => 20220313825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES [patent_app_type] => utility [patent_app_number] => 17/594454 [patent_app_country] => US [patent_app_date] => 2020-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60699 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -65 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594454 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/594454
PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES Apr 15, 2020 Pending
Array ( [id] => 18171712 [patent_doc_number] => 11571404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-07 [patent_title] => Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting [patent_app_type] => utility [patent_app_number] => 16/848952 [patent_app_country] => US [patent_app_date] => 2020-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28592 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848952 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/848952
Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting Apr 14, 2020 Issued
Array ( [id] => 17349947 [patent_doc_number] => 11224565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-18 [patent_title] => N-acyldipeptide derivatives and their uses [patent_app_type] => utility [patent_app_number] => 16/845513 [patent_app_country] => US [patent_app_date] => 2020-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18005 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845513 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/845513
N-acyldipeptide derivatives and their uses Apr 9, 2020 Issued
Array ( [id] => 16628716 [patent_doc_number] => 20210047369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => METHODS FOR REDUCING CD36 EXPRESSION [patent_app_type] => utility [patent_app_number] => 16/838290 [patent_app_country] => US [patent_app_date] => 2020-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9792 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16838290 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/838290
Methods for reducing CD36 expression Apr 1, 2020 Issued
Array ( [id] => 16451101 [patent_doc_number] => 20200360527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => Molecular-Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Intrarenal Deposition and Bioavailability [patent_app_type] => utility [patent_app_number] => 16/834715 [patent_app_country] => US [patent_app_date] => 2020-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834715 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/834715
Molecular-size of elastin-like polypeptide delivery system for therapeutics modulates intrarenal deposition and bioavailability Mar 29, 2020 Issued
Array ( [id] => 18056523 [patent_doc_number] => 20220387609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => BRANCHED DEGRADABLE POLYETHYLENE GLYCOL BINDER [patent_app_type] => utility [patent_app_number] => 17/599402 [patent_app_country] => US [patent_app_date] => 2020-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16109 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599402 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/599402
BRANCHED DEGRADABLE POLYETHYLENE GLYCOL BINDER Mar 25, 2020 Pending
Array ( [id] => 16175533 [patent_doc_number] => 20200222501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/829539 [patent_app_country] => US [patent_app_date] => 2020-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2529 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16829539 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/829539
PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION Mar 24, 2020 Abandoned
Array ( [id] => 17677065 [patent_doc_number] => 20220190232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => PIEZOELECTRIC PEPTIDE-BASED MATERIALS AND PIEZOELECTRIC DEVICES CONTAINING SAME [patent_app_type] => utility [patent_app_number] => 17/442765 [patent_app_country] => US [patent_app_date] => 2020-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16887 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442765 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/442765
PIEZOELECTRIC PEPTIDE-BASED MATERIALS AND PIEZOELECTRIC DEVICES CONTAINING SAME Mar 24, 2020 Pending
Array ( [id] => 16310921 [patent_doc_number] => 20200289659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => CONJUGATES FOR TREATING DISEASES [patent_app_type] => utility [patent_app_number] => 16/825566 [patent_app_country] => US [patent_app_date] => 2020-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44004 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825566 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/825566
CONJUGATES FOR TREATING DISEASES Mar 19, 2020 Abandoned
Array ( [id] => 16296266 [patent_doc_number] => 20200281989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => METHOD OF PREPARING A COMPOSITION FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 16/809385 [patent_app_country] => US [patent_app_date] => 2020-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809385 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/809385
METHOD OF PREPARING A COMPOSITION FOR TREATING CANCER Mar 3, 2020 Abandoned
Array ( [id] => 16090391 [patent_doc_number] => 20200199182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => MODIFIED LANTIBIOTICS AND METHODS OF MAKING AND USING THE MODIFIED LANTIBIOTICS [patent_app_type] => utility [patent_app_number] => 16/806641 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806641 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/806641
Modified lantibiotics and methods of making and using the modified lantibiotics Mar 1, 2020 Issued
Array ( [id] => 17702914 [patent_doc_number] => 20220202920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => METHOD FOR TREATING PREECLAMPSIA [patent_app_type] => utility [patent_app_number] => 17/429887 [patent_app_country] => US [patent_app_date] => 2020-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5748 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429887 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/429887
METHOD FOR TREATING PREECLAMPSIA Feb 9, 2020 Pending
Array ( [id] => 17480645 [patent_doc_number] => 20220088149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => Liquid Pharmaceutical Formulations of PTH Conjugates [patent_app_type] => utility [patent_app_number] => 17/428608 [patent_app_country] => US [patent_app_date] => 2020-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36359 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428608 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/428608
Liquid Pharmaceutical Formulations of PTH Conjugates Feb 9, 2020 Pending
Array ( [id] => 17546712 [patent_doc_number] => 20220118053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => Dry Pharmaceutical Formulations of CNP Conjugates [patent_app_type] => utility [patent_app_number] => 17/428604 [patent_app_country] => US [patent_app_date] => 2020-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428604 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/428604
Dry Pharmaceutical Formulations of CNP Conjugates Feb 9, 2020 Pending
Menu